Cargando…
An observational cohort study to assess N-acetylglucosamine for COVID-19 treatment in the inpatient setting
BACKGROUND: Coronavirus disease 2019 (COVID-19) has affected millions globally, with a continued need for effective treatments. N-acetylglucosamine has anti-inflammatory activities and modulates immune response. This study evaluated whether N-acetylglucosamine administered orally improves clinical o...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282940/ https://www.ncbi.nlm.nih.gov/pubmed/34306677 http://dx.doi.org/10.1016/j.amsu.2021.102574 |